PHARMACIE DE LA ROTONDE : revenue, balance sheet and financial ratios

PHARMACIE DE LA ROTONDE is a French company founded 8 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in AIX-EN-PROVENCE (13100), this company of category PME shows in 2023 a revenue of 5.3 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-04-25

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - PHARMACIE DE LA ROTONDE (SIREN 832398028)
Indicator 2024 2023 2022 2021 2020 2019
Revenue N/C 5 348 842 € 4 939 168 € 4 874 494 € 3 856 568 € 5 269 163 €
Net income 291 223 € 143 649 € 36 093 € -243 126 € -1 032 682 € -516 327 €
EBITDA N/C 368 532 € -176 757 € 185 272 € -417 218 € 14 154 €
Net margin N/C 2.7% 0.7% -5.0% -26.8% -9.8%

Revenue and income statement

In 2024, PHARMACIE DE LA ROTONDE generates positive net income of 291 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax.

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

291 223 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 190%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 31%. The balance between equity and debt is satisfactory.

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

189.513%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

30.73%

Solvency indicators evolution
PHARMACIE DE LA ROTONDE

Sector positioning

Debt ratio
189.51 2024
2022
2023
2024
Q1: 16.46
Med: 58.48
Q3: 154.77
Average +50 pts over 3 years

In 2024, the debt ratio of PHARMACIE DE LA ROTONDE (189.51) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
30.73% 2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Average

In 2024, the financial autonomy of PHARMACIE DE LA ROTONDE (30.7%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.

Repayment capacity
36.62 years 2023
2022
2023
Q1: 0.95 years
Med: 3.58 years
Q3: 7.48 years
Watch +50 pts over 2 years

In 2023, the repayment capacity of PHARMACIE DE LA ROTONDE (36.62) ranks in the top 25% of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A long duration may signal heavy debt relative to repayment capacity.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.

Operating WCR (2024) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2024) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

0 j

Supplier credit (2024) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

0 j

Inventory turnover (2024) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
PHARMACIE DE LA ROTONDE

Positioning of PHARMACIE DE LA ROTONDE in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 225 transactions of similar company sales in 2024, the value of PHARMACIE DE LA ROTONDE is estimated at 4 065 688 € (range 2 831 281€ - 6 082 502€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2024
225 transactions
2831k€ 4065k€ 6082k€
4 065 688 € Range: 2 831 281€ - 6 082 502€
NAF 5 année 2024

Valuation method used

Net Income Multiple
291 223 € × 14.0x = 4 065 688 €
Range: 2 831 281€ - 6 082 502€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare PHARMACIE DE LA ROTONDE with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about PHARMACIE DE LA ROTONDE

What is the revenue of PHARMACIE DE LA ROTONDE ?

The revenue of PHARMACIE DE LA ROTONDE in 2023 is 5.3 M€.

Is PHARMACIE DE LA ROTONDE profitable?

Yes, PHARMACIE DE LA ROTONDE generated a net profit of 291 k€ in 2024.

Where is the headquarters of PHARMACIE DE LA ROTONDE ?

The headquarters of PHARMACIE DE LA ROTONDE is located in AIX-EN-PROVENCE (13100), in the department Bouches-du-Rhone.

Where to find the tax return of PHARMACIE DE LA ROTONDE ?

The tax return of PHARMACIE DE LA ROTONDE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does PHARMACIE DE LA ROTONDE operate?

PHARMACIE DE LA ROTONDE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.